You have 9 free searches left this month | for more free features.

ADRS

Showing 1 - 25 of 529

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pharmacists' Knowledge and Attitudes About ADRs Reporting and

Completed
  • Adverse Drug Reaction
  • knwoledge
  • Fayoum, Egypt
    Marwa Kamal Ahmed Tolba
Feb 3, 2022

Proportion of Hepatic Toxicity and All Adverse Drug Reactions in

Completed
  • Hepatitis C
    • Tokyo, Japan
      Local Institution
    Feb 7, 2022

    Omics Sequencing of Exosomes in Body Fluids of Acute Lung Injury

    Recruiting
    • Acute Lung Injury
    • The lungs causes and extrapulmonary factors
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    May 9, 2022

    CVI - Common Variable Immunodeficiency Trial in Centennial (C1-esterase inhibitor [recombinant] (C1-INH-R))

    Completed
    • CVI - Common Variable Immunodeficiency
    • C1-esterase inhibitor [recombinant] (C1-INH-R)
    • Centennial, Colorado
      IMMUNOe Research Centers
    Feb 11, 2021

    DOAC ADRs Retrospective Study

    Terminated
    • Drug-Related Side Effects and Adverse Reactions
      • San Jose, California
        Santa Clara Valley Medical Center
      Mar 4, 2021

      VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During

      Not yet recruiting
      • Influenza Immunization (Healthy Volunteers)
      • Quadrivalent Influenza Vaccine
      • High-Dose Quadrivalent Influenza Vaccine
      • (no location specified)
      Sep 22, 2023

      VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During

      Completed
      • Influenza (Healthy Volunteers)
      • Quadrivalent Influenza Vaccine
      • High-Dose Quadrivalent Influenza Vaccine
      • Turku, Finland
      • +9 more
      Jan 4, 2023

      VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During

      Completed
      • Influenza (Healthy Volunteers)
      • Quadrivalent Influenza Vaccine
      • High-Dose Quadrivalent Influenza Vaccine
      • Helsinki, Finland
      • +14 more
      Dec 9, 2022

      Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

      Recruiting
      • SARS-CoV-2 Infection
        • Aichi, Japan
        • +2 more
        Jan 17, 2023

        Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

        Not yet recruiting
        • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
          • (no location specified)
          Dec 16, 2022

          Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance

          Active, not recruiting
          • Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
            • Aichi, Japan
            • +48 more
            Dec 7, 2022

            Safety of Nintedanib in Real World in China

            Not yet recruiting
            • Pulmonary Fibrosis
            • Beijing, China
              China-Japan Friendship Hospital
            Jan 26, 2023

            Association Between Genetic Variant Scores and DOACs (DARES2)

            Recruiting
            • Drug-Related Side Effects and Adverse Reactions
            • Iatrogenic Disorder
              • Seongnam-si, Gyonggi-do, Korea, Republic of
                SNUBH
              Jul 18, 2022

              Equfina Tablet 50 Milligram (mg)

              Recruiting
              • Parkinson Disease
              • +2 more
              • Equfina 50 mg
              • Cheongju, Chungcheongbuk-do, Korea, Republic of
              • +9 more
              Jan 26, 2022

              Nesina® Tablet Monotherapy or Combination Therapy in Type 2

              Completed
              • Type 2 Diabetes Mellitus
              • Alogliptin Benzoate
              • Andong, Korea, Republic of
              • +22 more
              Mar 31, 2022

              Tumors, Bone Marrow Transplantation Trial in Parkville (Release of Extended Pharmacogenomics Report at Week 1, Release of

              Not yet recruiting
              • Neoplasms
              • Bone Marrow Transplantation
              • Release of Extended Pharmacogenomics Report at Week 1
              • Release of Extended Pharmacogenomics Report at Week 13
              • Parkville, Victoria, Australia
                The Royal Children's Hospital
              Dec 19, 2022

              Active Pharmacovigilance of Anti-cancer Medicines

              Recruiting
              • Oncology
              • +2 more
                • Trieste, Italy
                  IRCCS materno infantile Burlo Garofolo
                Apr 11, 2023

                Pariet to Prevent Gastric and Duodenal Ulcer Associated With

                Recruiting
                • Stomach Ulcer
                • Duodenal Ulcer
                • Cheongju, Chungcheongbuk-do, Korea, Republic of
                • +28 more
                Jan 13, 2022

                LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

                Not yet recruiting
                • Breast Cancer
                  • (no location specified)
                  Jan 9, 2023

                  Proton Pump Inhibitor, Inappropriate Drug Use, Discontinuation Trial (Patient Journey App, Information folder)

                  Not yet recruiting
                  • Proton Pump Inhibitor
                  • +3 more
                  • Patient Journey App
                  • Information folder
                  • (no location specified)
                  Apr 20, 2022

                  Cardiovascular Drugs Adverse Reaction

                  Recruiting
                  • Pharmacogenetics
                  • +2 more
                  • Oral Anticoagulant, Direct-Acting
                  • Zagreb, Croatia
                    UHC Zagreb
                  Mar 23, 2022

                  Diabetes in Elderly People With Dementia in France

                  Completed
                  • Alzheimer Disease
                  • Incidence analysis
                  • Toulouse, France
                    University Hospital
                  Aug 31, 2021

                  Vonoprazan in the Real-world Clinical Practice in China

                  Recruiting
                  • Esophagitis Peptic
                    • Guangzhou, Guangdong, China
                    • +1 more
                    Aug 17, 2022

                    Long COVID, Brain Fog, Cognitive Impairment Trial (Speed of Processing Training, In-lab Instrumental Activities of Daily Living

                    Not yet recruiting
                    • Long COVID
                    • +4 more
                    • Speed of Processing Training
                    • +6 more
                    • (no location specified)
                    Oct 23, 2023

                    Lenvatinib in Combination With Pembrolizumab in Korean Patients

                    Recruiting
                    • Endometrial Neoplasms
                    • +2 more
                    • Non-interventional
                    • Ilsan, Gyeongji-do, Korea, Republic of
                    • +14 more
                    Nov 21, 2022